Cargando…
A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis
Genomics-driven drug discovery is indispensable for accelerating the development of novel therapeutic targets. However, the drug discovery framework based on evidence from genome-wide association studies (GWASs) has not been established, especially for cross-population GWAS meta-analysis. Here, we i...
Autores principales: | Namba, Shinichi, Konuma, Takahiro, Wu, Kuan-Han, Zhou, Wei, Okada, Yukinori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903693/ https://www.ncbi.nlm.nih.gov/pubmed/36778001 http://dx.doi.org/10.1016/j.xgen.2022.100190 |
Ejemplares similares
-
Integration of genetically regulated gene expression and pharmacological library provides therapeutic drug candidates
por: Konuma, Takahiro, et al.
Publicado: (2021) -
Genomics-driven drug discovery based on disease-susceptibility genes
por: Sonehara, Kyuto, et al.
Publicado: (2021) -
Statistical genetics and polygenic risk score for precision medicine
por: Konuma, Takahiro, et al.
Publicado: (2021) -
Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease
por: Zhou, Wei, et al.
Publicado: (2022) -
Genetic footprints of assortative mating in the Japanese population
por: Yamamoto, Kenichi, et al.
Publicado: (2022)